Back
RBC Target 2025 Government Bond ETF Vs. Aligos Therapeutics Industry Stock Comparison
Sell
30
RGQN.TO
RBC Target 2025 Government Bond ETF
Last Price:
20.54
Seasonality Move:
0.55%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
34.58
Seasonality Move:
10.65%
Sell
30
RBC Target 2025 Government Bond ETF (RGQN.TO)
is a Sell
Is RBC Target 2025 Government Bond ETF a Buy, Sell or Hold?
- The current RBC Target 2025 Government Bond ETF [RGQN.TO] share price is $20.54. The Score for RGQN.TO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RGQN.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RGQN.TO Stock Price Chart
What is RBC Target 2025 Government Bond ETF's stock price today?
-
The RBC Target 2025 Government Bond ETF share price today is $20.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGQN.TO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGQN.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 70.09 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.49 - 20.53) | Buy |
Bollinger Bands (100): | (20.36 - 20.5) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.71 | Buy |
Relative Strength Index (14 RSI): | 85.17 | Buy |
Chaikin Money Flow: | 491004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.08 - 27.66) | Buy |
Bollinger Bands (100): | (7.67 - 19.61) | Buy |
RGQN.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.53 | Buy |
20-day SMA: | 20.51 | Buy |
50-day SMA: | 20.49 | Buy |
200-day SMA: | 20.28 | Buy |
8-day EMA: | 20.53 | Buy |
20-day EMA: | 20.51 | Buy |
50-day EMA: | 20.48 | Buy |
200-day EMA: | 20.29 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.48 | Buy |
20-day SMA: | 23.64 | Buy |
50-day SMA: | 14.76 | Buy |
200-day SMA: | 15.86 | Buy |
8-day EMA: | 28.77 | Buy |
20-day EMA: | 23.99 | Buy |
50-day EMA: | 18.16 | Buy |
200-day EMA: | 16.13 | Buy |
RBC Target 2025 Government Bond ETF Earnings Growth & RGQN.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
RBC Target 2025 Government Bond ETF Technical Analysis
Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |